Information Provided By: 
Fly News Breaks for August 9, 2018
WMGI
Aug 9, 2018 | 05:23 EDT
Piper Jaffray analyst Matt O'Brien raised his price target for Wright Medical to $32 following the company's Q2 beat and guidance raise. Given the recent launch of Inject, meaningful new product launches expected in the second half of 2018, and continued momentum in the core franchise, Wright Medical "continues to be a solid growth story," O'Brien tells investors in a research note. The analyst keeps an Overweight rating on the shares.
News For WMGI From the Last 2 Days
There are no results for your query WMGI
